ExploreWatchlistsPricing
  1. JP-listed companies
  2. CHUGAI PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Operating expenses

CHUGAI PHARMACEUTICAL CO., LTD. (4519)

Market cap
¥14.42T
P/E ratio
35.2x
Chugai Pharmaceutical develops and sells prescription medicines in Japan and internationally, with research operations spanning the US, Europe, and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating expenses (Million JPY)YoY (%)
Dec 31, 2025116,461+5.78%
Dec 31, 2024110,098-2.20%
Dec 31, 2023112,580-56.74%
Dec 31, 2022260,242+4.95%
Dec 31, 2021247,979+11.59%
Dec 31, 2020222,217+5.21%
Dec 31, 2019211,205+6.81%
Dec 31, 2018197,744+7.34%
Dec 31, 2017184,224+6.48%
Dec 31, 2016173,018-1.98%
Dec 31, 2015176,520+6.74%
Dec 31, 2014165,381

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat